Cell Impact AB Statistics
Total Valuation
Cell Impact AB has a market cap or net worth of SEK 39.18 million. The enterprise value is 54.95 million.
| Market Cap | 39.18M |
| Enterprise Value | 54.95M |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cell Impact AB has 294.58 million shares outstanding. The number of shares has increased by 173.52% in one year.
| Current Share Class | 294.58M |
| Shares Outstanding | 294.58M |
| Shares Change (YoY) | +173.52% |
| Shares Change (QoQ) | +80.26% |
| Owned by Insiders (%) | 2.41% |
| Owned by Institutions (%) | 2.81% |
| Float | 287.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.89 |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.42 |
| EV / Sales | 9.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.16 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.02 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.56 |
| Interest Coverage | -20.96 |
Financial Efficiency
Return on equity (ROE) is -77.61% and return on invested capital (ROIC) is -26.79%.
| Return on Equity (ROE) | -77.61% |
| Return on Assets (ROA) | -25.09% |
| Return on Invested Capital (ROIC) | -26.79% |
| Return on Capital Employed (ROCE) | -66.57% |
| Weighted Average Cost of Capital (WACC) | 12.53% |
| Revenue Per Employee | 183,419 |
| Profits Per Employee | -4.26M |
| Employee Count | 31 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.23 |
Taxes
In the past 12 months, Cell Impact AB has paid 5,000 in taxes.
| Income Tax | 5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.36% in the last 52 weeks. The beta is 1.56, so Cell Impact AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -89.36% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.32 |
| Relative Strength Index (RSI) | 25.37 |
| Average Volume (20 Days) | 1,211,340 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cell Impact AB had revenue of SEK 5.69 million and -131.98 million in losses. Loss per share was -0.78.
| Revenue | 5.69M |
| Gross Profit | -4.97M |
| Operating Income | -85.21M |
| Pretax Income | -131.98M |
| Net Income | -131.98M |
| EBITDA | -55.03M |
| EBIT | -85.21M |
| Loss Per Share | -0.78 |
Balance Sheet
The company has 10.86 million in cash and 26.63 million in debt, with a net cash position of -15.77 million or -0.05 per share.
| Cash & Cash Equivalents | 10.86M |
| Total Debt | 26.63M |
| Net Cash | -15.77M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 121.03M |
| Book Value Per Share | 0.41 |
| Working Capital | 36.10M |
Cash Flow
In the last 12 months, operating cash flow was -45.36 million and capital expenditures -1.93 million, giving a free cash flow of -47.29 million.
| Operating Cash Flow | -45.36M |
| Capital Expenditures | -1.93M |
| Free Cash Flow | -47.29M |
| FCF Per Share | -0.16 |
Margins
| Gross Margin | -87.41% |
| Operating Margin | -1,498.66% |
| Pretax Margin | -2,321.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Cell Impact AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -173.52% |
| Shareholder Yield | -173.52% |
| Earnings Yield | -336.87% |
| FCF Yield | -120.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 25, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Cell Impact AB has an Altman Z-Score of -6.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.23 |
| Piotroski F-Score | 2 |